Skip to content

Ketogenic Diet for Reduction of CNS Oxygen Toxicity in Working Divers

Ketogenic Diet for Reduction of Oxygen Toxicity in Working Divers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03433261
Enrollment
91
Registered
2018-02-14
Start date
2018-03-01
Completion date
2021-10-30
Last updated
2021-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CNS Oxygen Toxicity, Ketogenic Diet

Brief summary

The purpose of this research study is to understand the effect of nutritional ketosis on CNS oxygen toxicity in undersea divers. The investigators hope this will provide a starting point to develop methods for improving the safety of Navy divers, warfighters and submariners.

Detailed description

Participants in the study will undergo a physical exam and testing as well as training on cognitive testing software as part of the screening process. Eligible subjects will be assigned a normal diet or a ketogenic diet (a diet high in fat/protein and low in carbohydrates) for three days before testing. Subjects will be immersed in water to the shoulders, inside a hyperbaric (high pressure) chamber while breathing 100% oxygen at increased atmospheric pressure, and doing cycling exercise. Testing on the cognitive software, as well as blood sampling and physical monitoring will be done while in the chamber. All tests and procedures will be completed again at least one week later with the diet not assigned for the first session.

Interventions

DIETARY_SUPPLEMENTKetogenic Diet

Eat a ketogenic diet (low carbohydrate, high fat diet) for 72 hrs prior to the experiment and consume a dietary ketone supplement 60 minutes before the experiment.

Sponsors

United States Department of Defense
CollaboratorFED
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Neither the investigator nor the outcomes assessor will no the ketone level of the participant during either arm of the study

Intervention model description

Each subject will randomize to one of two arms and will crossover to the other arm at least one week later.

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Males & females between 18 and 50 years old * Able to pedal a bicycle ergometer continuously for 15 minutes * Non-smoker * No history of cardiovascular disease, including coronary artery disease, valvular disease, cardiomyopathy or hypertension. * No history of lung disease

Exclusion criteria

* Prolonged QTc on initial ECG * Currently pregnant or attempting to become pregnant. * Have a history of: 1. Smoking 2. Coronary artery disease 3. Hypertension 4. Seizures 5. Exercise intolerance 6. Psychiatric disorder 7. Previous pneumothorax or pneumomediastinum 8. Hypo or hyperglycemia 9. Diabetes * Regularly take any medications which may alter heart rate, blood pressure, neurotransmitter function, mood or affect.

Design outcomes

Primary

MeasureTime frameDescription
Time to First Manifestations of CNS Oxygen Toxicity2 hrsTime to the first manifestation of CNS Oxygen Toxicity: visual or hearing changes, nausea, twitching, irritability, dizziness, convulsions or change consistent with possible CNS Oxygen Toxicity.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026